Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Adriana Weinberg

Concepts (833)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster Vaccine
25
2025
160
9.930
Why?
HIV Infections
97
2025
3017
9.900
Why?
Herpes Zoster
33
2025
319
9.360
Why?
Herpesvirus 3, Human
37
2025
336
7.490
Why?
Cytomegalovirus Infections
28
2024
197
6.070
Why?
Influenza Vaccines
29
2021
551
5.880
Why?
Immunity, Cellular
34
2025
269
5.730
Why?
Antibodies, Viral
44
2024
653
5.400
Why?
T-Lymphocytes, Regulatory
15
2025
393
4.770
Why?
Cytomegalovirus
27
2024
163
4.370
Why?
Pregnancy Complications, Infectious
24
2023
406
4.260
Why?
Influenza, Human
27
2021
626
3.980
Why?
Antiretroviral Therapy, Highly Active
22
2017
285
2.850
Why?
Influenza A Virus, H1N1 Subtype
13
2021
151
2.600
Why?
Respiratory Syncytial Virus, Human
6
2025
76
2.580
Why?
Vaccines, Attenuated
23
2024
130
2.560
Why?
Pneumococcal Infections
4
2022
110
2.540
Why?
T-Lymphocyte Subsets
12
2019
415
2.510
Why?
Anti-HIV Agents
18
2023
859
2.460
Why?
Immunologic Memory
14
2020
360
2.440
Why?
T-Lymphocytes
22
2020
2002
2.420
Why?
Leukocytes, Mononuclear
16
2025
573
2.320
Why?
CD4-Positive T-Lymphocytes
29
2023
1110
2.150
Why?
Respiratory Tract Infections
7
2025
385
2.110
Why?
Vaccination
23
2024
1467
1.660
Why?
Chickenpox
8
2024
81
1.650
Why?
Antiviral Agents
17
2023
747
1.590
Why?
Chickenpox Vaccine
11
2024
74
1.580
Why?
Humans
236
2025
141187
1.580
Why?
Interferon-gamma
20
2022
792
1.560
Why?
Drug Resistance, Viral
14
2017
120
1.460
Why?
HIV
8
2022
250
1.440
Why?
Female
162
2025
75515
1.440
Why?
Virus Diseases
4
2018
215
1.370
Why?
CD8-Positive T-Lymphocytes
12
2019
918
1.360
Why?
DNA, Viral
13
2024
366
1.340
Why?
Tetanus Toxoid
4
2021
37
1.310
Why?
Virus Shedding
6
2017
48
1.290
Why?
Pregnancy
42
2025
7070
1.280
Why?
Infectious Disease Transmission, Vertical
10
2023
186
1.270
Why?
Infant
42
2025
9818
1.230
Why?
Influenza A virus
9
2013
111
1.210
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
9
2009
28
1.200
Why?
Influenza B virus
9
2017
44
1.190
Why?
Respiratory Syncytial Virus Infections
2
2025
130
1.180
Why?
Hepatitis A Vaccines
5
2020
15
1.170
Why?
Antibodies, Bacterial
5
2022
146
1.140
Why?
Vaccines, Synthetic
7
2025
139
1.130
Why?
Adult
98
2025
39177
1.120
Why?
Dermatitis, Atopic
5
2020
331
1.110
Why?
B-Lymphocytes
7
2021
858
1.110
Why?
Cord Blood Stem Cell Transplantation
3
2023
101
1.100
Why?
Male
124
2025
69783
1.090
Why?
Adjuvants, Immunologic
8
2021
238
1.090
Why?
HIV-1
13
2019
895
1.030
Why?
CD4 Lymphocyte Count
17
2019
284
1.030
Why?
Antibody Formation
7
2023
298
1.010
Why?
Hemagglutination Inhibition Tests
14
2021
38
1.010
Why?
Anti-Retroviral Agents
8
2023
245
0.980
Why?
Pneumococcal Vaccines
3
2022
139
0.980
Why?
Lymphocyte Activation
26
2020
1150
0.970
Why?
Transforming Growth Factor beta
4
2025
497
0.960
Why?
Gastrointestinal Microbiome
2
2025
725
0.950
Why?
Breast Feeding
4
2023
444
0.940
Why?
Transforming Growth Factor beta1
2
2025
171
0.940
Why?
Interleukin-2
13
2022
453
0.910
Why?
Vaccines, Inactivated
10
2017
68
0.900
Why?
Respiratory Syncytial Viruses
1
2025
58
0.890
Why?
Monocytes
2
2025
579
0.890
Why?
Enzyme-Linked Immunospot Assay
6
2018
37
0.890
Why?
Hematopoietic Stem Cell Transplantation
3
2023
668
0.890
Why?
Viral Load
18
2023
506
0.880
Why?
Viremia
9
2021
150
0.880
Why?
Infant, Newborn
24
2025
6275
0.860
Why?
HIV Protease Inhibitors
3
2019
68
0.840
Why?
Child, Preschool
35
2025
11457
0.820
Why?
Immune Reconstitution
1
2023
8
0.810
Why?
Child
54
2025
22308
0.810
Why?
Epstein-Barr Virus Infections
5
2013
98
0.810
Why?
Environmental Exposure
2
2018
582
0.770
Why?
Papillomavirus Vaccines
3
2018
321
0.750
Why?
Herpesvirus 1, Human
3
2016
81
0.750
Why?
Receptors, Tumor Necrosis Factor
8
2001
166
0.740
Why?
Double-Blind Method
17
2021
1983
0.730
Why?
Adolescent
54
2025
22007
0.730
Why?
Cytokines
12
2025
2098
0.720
Why?
Middle Aged
63
2024
34434
0.700
Why?
Orthomyxoviridae
3
2017
40
0.700
Why?
Polymerase Chain Reaction
12
2023
1056
0.700
Why?
Young Adult
29
2023
13673
0.680
Why?
Latent Tuberculosis
1
2021
68
0.670
Why?
Aged
42
2024
24574
0.670
Why?
DNA-Directed DNA Polymerase
4
2008
47
0.660
Why?
Aged, 80 and over
18
2022
7856
0.660
Why?
Vitamin D
2
2024
397
0.650
Why?
Rotavirus Infections
2
2017
39
0.640
Why?
Herpesvirus 4, Human
8
2014
165
0.640
Why?
Viral Proteins
5
2012
369
0.640
Why?
Rotavirus Vaccines
2
2017
42
0.640
Why?
Immunosuppressive Agents
7
2014
854
0.620
Why?
Viral Envelope Proteins
2
2021
97
0.610
Why?
Tuberculosis
5
2023
285
0.600
Why?
Medroxyprogesterone Acetate
2
2016
39
0.590
Why?
Respiratory Syncytial Virus Vaccines
1
2019
38
0.590
Why?
Antibodies, Neutralizing
7
2021
305
0.590
Why?
RNA, Viral
9
2024
693
0.590
Why?
Isoniazid
5
2023
61
0.580
Why?
Paramyxoviridae Infections
2
2011
12
0.570
Why?
Simplexvirus
9
2016
82
0.570
Why?
Human papillomavirus 18
1
2018
16
0.570
Why?
Mycobacterium tuberculosis
1
2021
320
0.560
Why?
Human papillomavirus 16
1
2018
32
0.560
Why?
Immunocompromised Host
9
2019
203
0.560
Why?
Hepatitis A Antibodies
2
2009
3
0.560
Why?
Cryopreservation
2
2010
106
0.560
Why?
AIDS-Related Opportunistic Infections
3
2019
128
0.550
Why?
Th1 Cells
1
2018
139
0.540
Why?
Lymphocyte Subsets
2
2015
88
0.540
Why?
Antigens, Viral
8
2017
179
0.530
Why?
Immunoconjugates
2
2013
125
0.530
Why?
Flow Cytometry
11
2019
1197
0.520
Why?
Hospitalization
6
2021
2255
0.520
Why?
Immunization, Secondary
6
2017
88
0.520
Why?
Age Factors
9
2019
3292
0.520
Why?
Mutation
7
2009
4013
0.510
Why?
Acyclovir
6
2012
95
0.500
Why?
Herpesviridae Infections
5
2013
148
0.500
Why?
Premature Birth
2
2019
365
0.500
Why?
Encephalomyelitis, Autoimmune, Experimental
5
1999
68
0.490
Why?
Case-Control Studies
14
2024
3588
0.490
Why?
Host-Pathogen Interactions
1
2019
372
0.480
Why?
Viral Vaccines
4
2014
107
0.480
Why?
Herpes Simplex
4
2016
95
0.470
Why?
T-Lymphocytes, Cytotoxic
3
2011
174
0.470
Why?
Reagent Kits, Diagnostic
2
2005
35
0.460
Why?
Central Nervous System Viral Diseases
3
2004
77
0.450
Why?
Contraceptive Agents, Female
1
2016
81
0.450
Why?
B-Lymphocyte Subsets
1
2015
77
0.440
Why?
Immunoglobulin G
7
2021
900
0.440
Why?
Immunoassay
5
2017
113
0.440
Why?
Immunity, Mucosal
2
2012
96
0.430
Why?
Injections, Intramuscular
4
2017
131
0.430
Why?
Killer Cells, Natural
4
2025
469
0.430
Why?
Foscarnet
6
2008
20
0.430
Why?
Immunophenotyping
6
2019
329
0.410
Why?
Transplant Recipients
3
2024
178
0.410
Why?
Antigen-Presenting Cells
4
2022
159
0.400
Why?
Gene Expression Profiling
3
2019
1764
0.400
Why?
B-Lymphocytes, Regulatory
1
2013
3
0.400
Why?
Postpartum Period
5
2022
353
0.390
Why?
CD4 Antigens
2
2011
141
0.390
Why?
Influenza A Virus, H3N2 Subtype
4
2020
46
0.390
Why?
Staphylococcus aureus
1
2017
437
0.390
Why?
Reverse Transcriptase Inhibitors
3
2020
87
0.380
Why?
Immune Tolerance
2
2013
368
0.380
Why?
Alphapapillomavirus
1
2012
39
0.370
Why?
Hepatitis A
1
2012
26
0.370
Why?
Candida
3
2010
41
0.370
Why?
Vaccines, Conjugate
2
2022
64
0.370
Why?
Cohort Studies
11
2023
5799
0.370
Why?
Cell Proliferation
6
2020
2504
0.370
Why?
Placebos
5
2017
198
0.370
Why?
Polysaccharides
2
2022
87
0.360
Why?
Skin
1
2017
765
0.360
Why?
CD28 Antigens
3
2009
58
0.360
Why?
Immunity, Innate
2
2025
852
0.360
Why?
Metapneumovirus
1
2011
15
0.360
Why?
Contraceptive Agents
1
2012
66
0.360
Why?
Transplantation
1
2011
33
0.350
Why?
Herpesvirus 2, Human
2
2012
29
0.350
Why?
Lymphocyte Count
4
2019
167
0.350
Why?
Lymphoproliferative Disorders
1
2011
60
0.350
Why?
T-Lymphocytes, Helper-Inducer
7
1994
136
0.340
Why?
Retrospective Studies
21
2024
16273
0.340
Why?
Blood
2
2009
113
0.340
Why?
Pregnancy Outcome
7
2021
457
0.340
Why?
Nucleosides
1
2010
26
0.340
Why?
Drug Therapy, Combination
6
2019
1040
0.340
Why?
Antitubercular Agents
3
2023
207
0.330
Why?
Programmed Cell Death 1 Receptor
3
2020
257
0.320
Why?
Immunoglobulin A
4
2017
214
0.320
Why?
Streptococcus pneumoniae
2
2022
169
0.320
Why?
Cytosine
3
2008
48
0.320
Why?
Glycoproteins
2
2023
356
0.320
Why?
Adaptive Immunity
2
2017
173
0.320
Why?
Nucleotides
1
2010
127
0.320
Why?
Refrigeration
1
2009
12
0.310
Why?
Antidepressive Agents
3
2021
254
0.310
Why?
Membrane Glycoproteins
4
2001
501
0.310
Why?
Follow-Up Studies
16
2024
5200
0.310
Why?
Immunity, Humoral
2
2021
117
0.310
Why?
Enzyme-Linked Immunosorbent Assay
8
2021
855
0.310
Why?
Organophosphonates
3
2008
99
0.310
Why?
Astrocytes
1
2011
217
0.300
Why?
Freezing
1
2009
88
0.300
Why?
Coculture Techniques
2
2025
245
0.300
Why?
Cytomegalovirus Retinitis
2
2013
21
0.300
Why?
Tetanus
2
2009
27
0.290
Why?
Lopinavir
3
2023
31
0.290
Why?
Benzoxazines
3
2023
33
0.280
Why?
Time Factors
18
2017
6956
0.280
Why?
Interleukin-10
3
2022
310
0.280
Why?
Herpesvirus 7, Human
2
2005
6
0.280
Why?
Prospective Studies
14
2024
7739
0.280
Why?
Immunogenicity, Vaccine
4
2021
34
0.280
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2008
101
0.280
Why?
Longitudinal Studies
8
2019
2902
0.280
Why?
Herpesvirus 6, Human
2
2005
14
0.280
Why?
Specimen Handling
1
2009
182
0.270
Why?
Glioblastoma
1
2011
347
0.270
Why?
Norgestrel
1
2007
2
0.270
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
987
0.270
Why?
Interleukins
2
2008
248
0.270
Why?
Biomarkers
7
2021
4174
0.260
Why?
Apoptosis
6
2011
2574
0.260
Why?
Incidence
9
2023
2794
0.260
Why?
Nucleic Acid Hybridization
2
2006
189
0.250
Why?
Antigens, CD
5
2017
539
0.250
Why?
Lung Transplantation
4
2002
322
0.240
Why?
Coinfection
2
2019
137
0.240
Why?
Fibroblasts
4
2025
1020
0.230
Why?
Lymphokines
5
1994
133
0.230
Why?
Bone Marrow Transplantation
2
2005
294
0.230
Why?
Ritonavir
2
2016
75
0.230
Why?
A549 Cells
1
2025
74
0.220
Why?
Receptors, OX40
8
2001
15
0.220
Why?
Dexamethasone
1
2007
380
0.220
Why?
Cell Survival
5
2010
1129
0.220
Why?
Roseolovirus Infections
1
2004
8
0.220
Why?
Paramyxoviridae
1
2004
2
0.220
Why?
Measles Vaccine
1
2024
21
0.220
Why?
Virus Replication
5
2017
532
0.220
Why?
RNA, Messenger
10
2011
2828
0.210
Why?
BCG Vaccine
2
2023
24
0.210
Why?
Forkhead Transcription Factors
3
2011
199
0.210
Why?
Ganciclovir
4
2008
53
0.210
Why?
Milk, Human
2
2023
169
0.210
Why?
Autoimmune Diseases
3
2014
464
0.210
Why?
Immunity
2
2020
140
0.210
Why?
Brazil
2
2021
173
0.210
Why?
Cholecalciferol
1
2024
61
0.210
Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
256
0.210
Why?
Estradiol
1
2007
528
0.200
Why?
Myelin Basic Protein
4
1998
44
0.200
Why?
Orthomyxoviridae Infections
1
2004
68
0.200
Why?
Abnormalities, Drug-Induced
1
2023
29
0.200
Why?
Maternal-Fetal Exchange
2
2016
172
0.200
Why?
Acquired Immunodeficiency Syndrome
2
2023
235
0.200
Why?
Down-Regulation
1
2025
641
0.200
Why?
Kaposi Varicelliform Eruption
3
2011
21
0.200
Why?
Long-Term Care
1
2024
110
0.200
Why?
Adenoviridae Infections
1
2023
19
0.200
Why?
Heart Transplantation
10
2001
714
0.190
Why?
Papillomavirus Infections
2
2018
380
0.190
Why?
Diabetes Mellitus, Type 1
4
2013
3776
0.190
Why?
Isoxazoles
2
2013
54
0.190
Why?
United States
9
2024
15220
0.190
Why?
Liver Failure, Acute
1
2023
64
0.190
Why?
Zidovudine
2
2015
79
0.190
Why?
Lamivudine
2
2015
65
0.190
Why?
Herpes Genitalis
2
2012
18
0.190
Why?
HIV Integrase Inhibitors
1
2023
72
0.190
Why?
Dendritic Cells
1
2025
505
0.190
Why?
Risk Factors
18
2024
10438
0.190
Why?
Genes, Immediate-Early
1
2002
25
0.180
Why?
Cyclopropanes
2
2020
71
0.180
Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
96
0.180
Why?
Lymphocytosis
1
2021
11
0.180
Why?
South Africa
6
2020
240
0.180
Why?
Genes, Viral
1
2002
92
0.180
Why?
Central Nervous System Diseases
1
2002
73
0.180
Why?
Alkynes
2
2020
63
0.180
Why?
Antigens, Differentiation
1
2001
82
0.180
Why?
Tuberculin Test
1
2021
36
0.180
Why?
Biliary Atresia
1
2023
153
0.180
Why?
Cytotoxicity, Immunologic
2
2002
226
0.180
Why?
Interferon-gamma Release Tests
1
2021
33
0.180
Why?
Organ Transplantation
1
2024
250
0.170
Why?
Cells, Cultured
11
2010
4208
0.170
Why?
Phenotype
7
2009
3166
0.170
Why?
Maternal Exposure
1
2023
202
0.170
Why?
Atazanavir Sulfate
2
2023
44
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
Why?
Medication Therapy Management
1
2021
79
0.170
Why?
Virus Activation
3
2013
86
0.170
Why?
Immunoglobulins
2
2017
168
0.170
Why?
Evolution, Molecular
1
2005
510
0.170
Why?
North America
2
2023
306
0.170
Why?
Receptors, Immunologic
2
2000
215
0.170
Why?
Sensitivity and Specificity
5
2009
1973
0.160
Why?
HIV Seronegativity
1
2020
30
0.160
Why?
Histocompatibility Antigens Class I
1
2002
209
0.160
Why?
Virus Cultivation
3
2005
31
0.160
Why?
RNA, Ribosomal, 16S
1
2022
557
0.160
Why?
Dietary Supplements
1
2024
566
0.150
Why?
Heart-Assist Devices
8
2000
559
0.150
Why?
Treatment Outcome
16
2017
11120
0.150
Why?
T-Cell Antigen Receptor Specificity
1
2019
51
0.150
Why?
Interleukin-2 Receptor alpha Subunit
1
2019
80
0.150
Why?
Inflammation
4
2019
2890
0.150
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
2017
15
0.150
Why?
Eicosanoids
1
2019
63
0.150
Why?
Survival Analysis
6
2018
1319
0.150
Why?
Abatacept
2
2013
56
0.150
Why?
Dose-Response Relationship, Immunologic
2
2016
85
0.150
Why?
Cholera Toxin
1
2018
31
0.150
Why?
Postoperative Complications
14
2001
2797
0.150
Why?
Hospitals
1
2023
696
0.140
Why?
Saliva
2
2010
245
0.140
Why?
Neurodevelopmental Disorders
1
2021
196
0.140
Why?
Fatty Acid-Binding Proteins
1
2018
71
0.140
Why?
Delayed-Action Preparations
2
2016
177
0.140
Why?
Genotype
6
2020
1859
0.140
Why?
Latin America
1
2018
91
0.140
Why?
Depressive Disorder, Major
2
2013
374
0.140
Why?
Cell Movement
2
2001
990
0.140
Why?
Lysosomal-Associated Membrane Protein 1
1
2017
6
0.140
Why?
CD4-CD8 Ratio
2
2008
24
0.140
Why?
Vaccination Coverage
1
2018
96
0.130
Why?
Coronary Artery Bypass
4
2001
243
0.130
Why?
Injections, Intradermal
1
2017
12
0.130
Why?
Cell Line
5
2009
2885
0.130
Why?
Injections, Subcutaneous
2
2016
165
0.130
Why?
Nervous System Diseases
1
2020
275
0.130
Why?
Paralysis
1
2017
70
0.130
Why?
Placenta
2
2021
761
0.130
Why?
Arm
1
2017
108
0.130
Why?
Seroconversion
1
2017
46
0.130
Why?
Africa
1
2017
119
0.130
Why?
Kinetics
3
2010
1652
0.130
Why?
Nelfinavir
1
2016
9
0.120
Why?
Animals
24
2011
37657
0.120
Why?
Seizures
1
2020
442
0.120
Why?
Clinical Trials as Topic
2
2019
1052
0.120
Why?
Adoptive Transfer
3
2002
223
0.120
Why?
Cross Reactions
2
2014
133
0.120
Why?
Base Sequence
6
2017
2180
0.120
Why?
Aging
3
2017
1892
0.120
Why?
Liver Transplantation
1
2023
766
0.120
Why?
Demography
2
2018
296
0.120
Why?
Colorado
2
2023
4610
0.120
Why?
Comorbidity
2
2019
1662
0.120
Why?
Nevirapine
1
2015
18
0.120
Why?
RNA
1
2022
930
0.120
Why?
Contraceptives, Oral, Synthetic
1
2015
1
0.120
Why?
Nasopharynx
1
2015
74
0.110
Why?
Nasal Lavage Fluid
2
2005
15
0.110
Why?
Virus Latency
2
2013
80
0.110
Why?
Infant, Newborn, Diseases
1
2016
113
0.110
Why?
Immunoenzyme Techniques
2
2006
209
0.110
Why?
Skin Diseases
1
2016
147
0.110
Why?
Neutropenia
1
2015
157
0.110
Why?
Transcription, Genetic
1
2021
1487
0.110
Why?
Seroepidemiologic Studies
2
2024
166
0.110
Why?
Multivariate Analysis
5
2017
1490
0.110
Why?
Computational Biology
1
2019
661
0.110
Why?
Antigens, Differentiation, T-Lymphocyte
1
1994
97
0.110
Why?
Pandemics
2
2021
1653
0.110
Why?
Graft Rejection
5
2001
544
0.110
Why?
Physical Fitness
1
2015
206
0.100
Why?
Herpesvirus 8, Human
2
2005
66
0.100
Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
Why?
Anemia
1
2015
177
0.100
Why?
Feces
1
2017
504
0.100
Why?
Progesterone
2
2015
260
0.100
Why?
Thrombocytopenia
1
2015
208
0.100
Why?
Leukocyte Common Antigens
2
2009
90
0.100
Why?
Anesthesiology
1
2016
169
0.100
Why?
Polyomavirus Infections
1
2013
30
0.100
Why?
Tumor Virus Infections
1
2013
50
0.100
Why?
Epitopes
2
2009
477
0.100
Why?
Epitopes, T-Lymphocyte
1
2014
184
0.100
Why?
OX40 Ligand
4
2001
10
0.100
Why?
Transcriptome
1
2019
1003
0.100
Why?
Mothers
1
2019
785
0.100
Why?
Proctitis
1
2012
7
0.090
Why?
Oxadiazoles
1
2012
33
0.090
Why?
Oxidative Stress
1
2019
1330
0.090
Why?
Rats, Inbred Lew
4
1998
113
0.090
Why?
Aprotinin
3
1997
9
0.090
Why?
HIV Seropositivity
1
2013
127
0.090
Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
Why?
Depression
1
2021
1483
0.090
Why?
DNA Primase
1
2012
47
0.090
Why?
Communicable Diseases
1
2014
161
0.090
Why?
Mycophenolic Acid
1
2012
118
0.090
Why?
Fluorescent Antibody Technique, Direct
1
2011
10
0.090
Why?
Viral Plaque Assay
3
2006
34
0.090
Why?
L-Selectin
2
2009
24
0.090
Why?
Histocompatibility Testing
3
2001
123
0.090
Why?
Receptors, Interleukin-2
2
1990
66
0.090
Why?
CD8 Antigens
1
2011
75
0.090
Why?
Guanine
3
2006
81
0.090
Why?
Encephalitis, Viral
2
2020
45
0.090
Why?
Ribavirin
1
2011
82
0.090
Why?
DNA Helicases
1
2012
140
0.080
Why?
Immunization Schedule
3
2020
203
0.080
Why?
Fluorescent Antibody Technique
2
2016
386
0.080
Why?
Parturition
1
2011
67
0.080
Why?
Motor Activity
1
2015
717
0.080
Why?
Length of Stay
3
2014
1254
0.080
Why?
Predictive Value of Tests
3
2005
2070
0.080
Why?
Logistic Models
5
2010
2086
0.080
Why?
Herpesvirus Vaccines
1
2010
4
0.080
Why?
Menstrual Cycle
1
2011
134
0.080
Why?
Fetal Blood
2
2019
341
0.080
Why?
Algorithms
3
2021
1763
0.080
Why?
Herpes Simplex Virus Vaccines
1
2009
4
0.080
Why?
Granzymes
1
2009
50
0.080
Why?
Pokeweed Mitogens
1
2009
7
0.080
Why?
Immune System
2
2008
183
0.080
Why?
Human Experimentation
1
2009
14
0.080
Why?
Neuralgia, Postherpetic
1
2009
40
0.080
Why?
Immunologic Factors
1
2011
248
0.080
Why?
Drug Stability
1
2009
166
0.080
Why?
Plasma
2
2018
220
0.070
Why?
Cost of Illness
1
2011
312
0.070
Why?
Apoptosis Regulatory Proteins
1
2009
194
0.070
Why?
Gene Rearrangement, T-Lymphocyte
1
2008
16
0.070
Why?
Nasal Mucosa
1
2009
106
0.070
Why?
Mice
13
2011
18048
0.070
Why?
Tumor Necrosis Factor-alpha
1
2014
1250
0.070
Why?
Inflammation Mediators
1
2011
519
0.070
Why?
Botswana
2
2019
11
0.070
Why?
Enzyme Inhibitors
1
2012
854
0.070
Why?
Betaherpesvirinae
1
2008
1
0.070
Why?
Infant Mortality
2
2019
121
0.070
Why?
Genetic Variation
2
2011
1000
0.070
Why?
Exodeoxyribonucleases
1
2008
22
0.070
Why?
Administration, Intranasal
1
2008
92
0.070
Why?
Interleukin-15
1
2008
101
0.070
Why?
Cyclosporine
2
2001
265
0.070
Why?
Sarcoma
1
2010
190
0.070
Why?
Interleukin-12
1
2008
123
0.070
Why?
Trypan Blue
1
2007
6
0.070
Why?
Rats
5
1998
5629
0.070
Why?
Didanosine
1
2007
13
0.070
Why?
Thymus Gland
1
2008
319
0.070
Why?
Gene Expression
3
2006
1491
0.070
Why?
In Vitro Techniques
3
2006
1093
0.070
Why?
Quality Control
1
2007
171
0.070
Why?
Data Interpretation, Statistical
1
2009
376
0.070
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2010
286
0.060
Why?
Multicenter Studies as Topic
2
2006
338
0.060
Why?
Inhibitory Concentration 50
1
2006
91
0.060
Why?
Vero Cells
1
2006
87
0.060
Why?
Cerebrospinal Fluid
2
2004
92
0.060
Why?
Randomized Controlled Trials as Topic
2
2011
1556
0.060
Why?
Pneumonia
1
2013
656
0.060
Why?
Veterans
1
2018
1514
0.060
Why?
Transfection
3
2002
943
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2012
852
0.060
Why?
Drug Interactions
2
2020
406
0.060
Why?
Deoxycytidine
1
2007
192
0.060
Why?
Opportunistic Infections
2
2014
45
0.060
Why?
Protein Structure, Tertiary
1
2008
859
0.060
Why?
Hemostatics
2
1997
58
0.060
Why?
Risk Assessment
2
2014
3490
0.060
Why?
Hemadsorption
1
2005
1
0.060
Why?
Cytopathogenic Effect, Viral
1
2005
16
0.060
Why?
Disease Models, Animal
2
2011
4404
0.060
Why?
Tumor Necrosis Factors
3
2001
11
0.060
Why?
Signal Transduction
2
2000
5144
0.060
Why?
Evaluation Studies as Topic
1
2005
175
0.060
Why?
Gene Products, pol
1
2005
6
0.060
Why?
Annexin A5
1
2004
26
0.060
Why?
Clinical Trials, Phase II as Topic
2
2017
73
0.060
Why?
Cysteine Proteinase Inhibitors
1
2004
49
0.060
Why?
Antigens
2
2008
362
0.060
Why?
Meningitis, Viral
1
2004
20
0.060
Why?
Measles virus
1
2024
20
0.050
Why?
Parainfluenza Virus 2, Human
1
2004
3
0.050
Why?
Parainfluenza Virus 1, Human
1
2004
3
0.050
Why?
Parainfluenza Virus 3, Human
1
2004
5
0.050
Why?
Sarcoma, Kaposi
2
2003
80
0.050
Why?
Transplantation, Homologous
2
2002
413
0.050
Why?
Disease Transmission, Infectious
1
2005
69
0.050
Why?
Adenoviruses, Human
1
2004
27
0.050
Why?
Emtricitabine
2
2021
205
0.050
Why?
Cell Culture Techniques
1
2006
368
0.050
Why?
Fatal Outcome
1
2005
309
0.050
Why?
Chlamydophila Infections
1
2003
5
0.050
Why?
Chlamydophila pneumoniae
1
2003
12
0.050
Why?
Measles
1
2024
46
0.050
Why?
Immunotherapy, Adoptive
2
2001
356
0.050
Why?
Survival Rate
8
2001
1970
0.050
Why?
Rilpivirine
1
2023
9
0.050
Why?
HLA-DR Antigens
3
2001
228
0.050
Why?
Hospital Mortality
4
2001
924
0.050
Why?
Arteriosclerosis
1
2003
83
0.050
Why?
Portoenterostomy, Hepatic
1
2023
42
0.050
Why?
Cell Line, Tumor
1
2011
3469
0.050
Why?
Leukemia, Myeloid, Acute
1
2010
646
0.050
Why?
Bronchiolitis Obliterans
2
2001
65
0.050
Why?
Darunavir
1
2023
19
0.050
Why?
Herpes Labialis
1
2003
8
0.050
Why?
DNA Primers
3
2009
510
0.050
Why?
Respirovirus
1
2002
6
0.050
Why?
Pregnancy Trimester, First
1
2023
138
0.050
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
1994
335
0.050
Why?
Bronchoalveolar Lavage Fluid
1
2005
650
0.050
Why?
Parapsychology
1
2001
1
0.050
Why?
Risk
1
2005
904
0.050
Why?
Adenoviridae
1
2023
201
0.050
Why?
Electromagnetic Fields
1
2001
38
0.050
Why?
Zimbabwe
2
2017
61
0.050
Why?
B7-1 Antigen
2
1998
58
0.040
Why?
Microbial Sensitivity Tests
1
2003
370
0.040
Why?
Ovalbumin
1
2001
196
0.040
Why?
Cobicistat
1
2021
5
0.040
Why?
Molecular Sequence Data
4
1994
2929
0.040
Why?
Receptors, CXCR5
1
2021
23
0.040
Why?
CTLA-4 Antigen
1
2001
101
0.040
Why?
Rituximab
2
2013
204
0.040
Why?
Antibody Affinity
1
2021
60
0.040
Why?
Photography
1
2001
115
0.040
Why?
Liver Diseases
1
2024
301
0.040
Why?
Vaccines, Subunit
1
2021
50
0.040
Why?
Immunoglobulins, Intravenous
1
2002
128
0.040
Why?
Lymphoma
1
2002
228
0.040
Why?
Prostheses and Implants
3
1996
144
0.040
Why?
Equivalence Trials as Topic
1
2020
12
0.040
Why?
Arylamine N-Acetyltransferase
1
2020
7
0.040
Why?
Cytochrome P-450 CYP2B6
1
2020
10
0.040
Why?
Gene Expression Regulation
1
1990
2599
0.040
Why?
Models, Statistical
1
2005
671
0.040
Why?
Pre-Eclampsia
1
2023
202
0.040
Why?
Sentinel Lymph Node Biopsy
1
2001
115
0.040
Why?
Analysis of Variance
2
2016
1320
0.040
Why?
Living Donors
1
2023
268
0.040
Why?
Metabolic Clearance Rate
1
2020
116
0.040
Why?
Spinal Cord
2
1994
373
0.040
Why?
Surface Properties
1
2001
412
0.040
Why?
Heart Failure
3
1999
2088
0.040
Why?
Glioma
1
2005
427
0.040
Why?
DNA
2
2006
1444
0.040
Why?
Central Nervous System Neoplasms
1
2002
169
0.040
Why?
Alanine
1
2021
153
0.040
Why?
Trans-Activators
1
2002
388
0.040
Why?
Lymphatic Metastasis
1
2001
326
0.040
Why?
Confusion
1
2020
30
0.040
Why?
Cancer Vaccines
1
2001
167
0.040
Why?
Hemodynamics
3
2001
1100
0.040
Why?
Coronary Disease
2
2001
371
0.040
Why?
Antibodies
1
2001
409
0.040
Why?
Interleukin-3
3
1994
24
0.040
Why?
Prognosis
3
2024
4073
0.040
Why?
Liver Function Tests
1
2019
105
0.040
Why?
Acetates
1
2019
79
0.040
Why?
California
2
2015
462
0.040
Why?
Candidiasis
1
1999
63
0.040
Why?
Triiodothyronine
1
1999
50
0.040
Why?
Recombinant Fusion Proteins
2
1999
672
0.040
Why?
Infant, Very Low Birth Weight
1
2019
70
0.040
Why?
Hemagglutination
1
2018
8
0.040
Why?
Macrophage-1 Antigen
1
1999
28
0.040
Why?
Tenofovir
1
2021
276
0.040
Why?
Cross-Sectional Studies
3
2024
5636
0.040
Why?
Arginine Vasopressin
1
1998
43
0.040
Why?
Polymorphism, Single Nucleotide
3
2011
2132
0.040
Why?
Hypoplastic Left Heart Syndrome
1
2000
118
0.040
Why?
Mice, Inbred BALB C
1
2001
1274
0.040
Why?
Brain Diseases
1
2020
149
0.040
Why?
Neoplasms
3
2001
2741
0.040
Why?
Adenine
1
2021
301
0.040
Why?
Pilot Projects
1
2024
1820
0.040
Why?
Haptoglobins
1
2018
56
0.040
Why?
Quinazolines
1
2019
250
0.040
Why?
HLA-B Antigens
1
1998
64
0.030
Why?
Vasoconstrictor Agents
1
1998
134
0.030
Why?
Chronic Disease
1
2024
1816
0.030
Why?
Antibody Specificity
1
1998
187
0.030
Why?
Delivery, Obstetric
1
2019
163
0.030
Why?
Protein Precursors
1
2018
133
0.030
Why?
Clinical Trials, Phase I as Topic
1
2017
51
0.030
Why?
Shock
1
1998
103
0.030
Why?
Inositol Phosphates
1
2017
22
0.030
Why?
Sterols
1
2017
20
0.030
Why?
Immunization
1
2020
406
0.030
Why?
Autogenic Training
1
1997
1
0.030
Why?
Proviruses
1
2017
16
0.030
Why?
Radioactive Fallout
1
1997
1
0.030
Why?
Leukemia, Radiation-Induced
1
1997
4
0.030
Why?
Product Surveillance, Postmarketing
1
2017
68
0.030
Why?
Radioactive Hazard Release
1
1997
3
0.030
Why?
Sequence Analysis
1
2017
36
0.030
Why?
Power Plants
1
1997
9
0.030
Why?
Zambia
1
2017
57
0.030
Why?
Relaxation Therapy
1
1997
19
0.030
Why?
Tanzania
1
2017
59
0.030
Why?
Observational Studies as Topic
1
2017
123
0.030
Why?
Reproducibility of Results
1
2005
3348
0.030
Why?
Encephalitis
1
1998
137
0.030
Why?
Lung Injury
1
2000
227
0.030
Why?
Ligands
1
1999
667
0.030
Why?
Heart Valves
1
1997
42
0.030
Why?
Aortic Valve Insufficiency
1
1996
44
0.030
Why?
Prevalence
2
2018
2772
0.030
Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2016
25
0.030
Why?
Erythema
1
2016
28
0.030
Why?
Neoplasms, Radiation-Induced
1
1997
103
0.030
Why?
Body Weight
1
2020
996
0.030
Why?
Fiber Optic Technology
1
2016
24
0.030
Why?
Up-Regulation
2
2001
859
0.030
Why?
Heart Arrest, Induced
1
1995
34
0.030
Why?
Thromboembolism
1
1996
118
0.030
Why?
Graft vs Host Disease
1
1998
254
0.030
Why?
Chi-Square Distribution
2
2013
521
0.030
Why?
Intestines
1
2018
357
0.030
Why?
Vasodilation
1
1998
516
0.030
Why?
Single-Blind Method
1
2016
288
0.030
Why?
Reference Values
2
2011
805
0.030
Why?
Registries
1
2024
2135
0.030
Why?
DNA-Binding Proteins
1
2002
1478
0.030
Why?
Blood Transfusion
2
1995
392
0.030
Why?
Interleukin-4
2
1998
215
0.030
Why?
Ovulation
1
2015
40
0.030
Why?
Liver
1
2023
1819
0.030
Why?
Antibodies, Monoclonal
2
2001
1448
0.030
Why?
Gene Regulatory Networks
1
2017
313
0.030
Why?
Cross Infection
1
1997
254
0.030
Why?
Hematologic Neoplasms
1
1997
159
0.030
Why?
Hypothermia, Induced
1
1995
92
0.030
Why?
Rats, Inbred BUF
1
1994
1
0.030
Why?
Blood Loss, Surgical
1
1995
112
0.030
Why?
HLA-A2 Antigen
1
2014
49
0.030
Why?
Surgical Wound Infection
1
1997
319
0.030
Why?
Aortic Coarctation
1
1994
80
0.030
Why?
Polymorphism, Restriction Fragment Length
2
2003
68
0.030
Why?
Quality of Life
4
2000
2999
0.030
Why?
Pulmonary Emphysema
1
1996
312
0.030
Why?
Myocardial Infarction
1
2001
1069
0.030
Why?
Colony-Stimulating Factors
2
1990
37
0.030
Why?
Cross-Over Studies
1
2016
578
0.030
Why?
Aortic Valve
1
1996
359
0.030
Why?
Cause of Death
3
2001
440
0.020
Why?
BK Virus
1
2013
16
0.020
Why?
Intubation, Intratracheal
1
2016
286
0.020
Why?
Growth Substances
2
1990
148
0.020
Why?
JC Virus
1
2013
23
0.020
Why?
Herpesviridae
1
2012
22
0.020
Why?
Mice, Inbred Strains
2
1990
412
0.020
Why?
Genetic Predisposition to Disease
2
2011
2363
0.020
Why?
Drug Administration Schedule
2
2007
771
0.020
Why?
Cardiac Surgical Procedures
1
1998
585
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
1990
159
0.020
Why?
Hypersensitivity, Delayed
1
1992
30
0.020
Why?
Heart Diseases
1
1995
335
0.020
Why?
Ventricular Function, Left
1
1995
513
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
1787
0.020
Why?
Brain Neoplasms
1
2001
1304
0.020
Why?
Spleen
1
1994
525
0.020
Why?
Kaplan-Meier Estimate
1
2014
908
0.020
Why?
Ambulatory Care
1
1996
582
0.020
Why?
Patient Selection
1
1995
688
0.020
Why?
Sex Characteristics
1
2017
788
0.020
Why?
Metabolomics
1
2017
704
0.020
Why?
Histocompatibility Antigens
1
1992
107
0.020
Why?
Computer Simulation
1
2016
1015
0.020
Why?
Matched-Pair Analysis
1
2011
38
0.020
Why?
Receptors, Interferon
1
2011
52
0.020
Why?
Stroke
1
2000
1154
0.020
Why?
Administration, Oral
1
2013
803
0.020
Why?
Kidney Failure, Chronic
1
1997
596
0.020
Why?
Age of Onset
1
2012
532
0.020
Why?
Radiotherapy
2
2005
208
0.020
Why?
Cattle
2
1990
998
0.020
Why?
Lung Neoplasms
2
2001
2560
0.020
Why?
Polyribosomes
1
1990
24
0.020
Why?
Cell Separation
1
2011
317
0.020
Why?
Sequence Homology, Nucleic Acid
1
1990
156
0.020
Why?
Concanavalin A
1
1990
75
0.020
Why?
Tetradecanoylphorbol Acetate
1
1990
156
0.020
Why?
Regulatory Sequences, Nucleic Acid
1
1990
92
0.020
Why?
Blotting, Northern
1
1990
198
0.020
Why?
Haplotypes
1
2011
496
0.020
Why?
Infant, Premature
1
2014
597
0.020
Why?
Genetic Association Studies
1
2011
372
0.020
Why?
Papillomaviridae
1
2010
133
0.020
Why?
beta-Globins
1
2009
8
0.020
Why?
Mice, Knockout
2
2011
3068
0.020
Why?
Herpesvirus 1, Bovine
1
1989
3
0.020
Why?
Cell Division
2
2002
798
0.020
Why?
Practice Guidelines as Topic
1
2017
1597
0.020
Why?
Anxiety
1
1997
1082
0.020
Why?
Prenatal Exposure Delayed Effects
1
2016
662
0.020
Why?
Ribosomes
1
1990
186
0.020
Why?
Immunoglobulin E
1
2010
331
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
761
0.020
Why?
Hematopoietic Stem Cells
2
1990
411
0.020
Why?
Arthritis, Rheumatoid
1
1998
1176
0.020
Why?
Reference Standards
1
2009
186
0.020
Why?
Phylogeny
1
2013
1018
0.020
Why?
Multiple Sclerosis
1
1994
468
0.020
Why?
Linear Models
1
2010
857
0.020
Why?
Infusions, Intravenous
2
1999
417
0.020
Why?
Membrane Proteins
1
1994
1154
0.020
Why?
Clinical Competence
1
2016
1202
0.020
Why?
Protein Biosynthesis
1
1990
444
0.020
Why?
Time
1
2007
87
0.020
Why?
Kidney Transplantation
1
2013
675
0.020
Why?
Drug Resistance, Multiple
1
2006
25
0.020
Why?
Antineoplastic Agents
2
2010
2166
0.020
Why?
Clinical Protocols
1
2007
273
0.010
Why?
Templates, Genetic
1
2005
63
0.010
Why?
Cell Differentiation
4
2000
2003
0.010
Why?
Postoperative Care
2
1999
279
0.010
Why?
Codon
1
2005
92
0.010
Why?
Internship and Residency
1
2016
1235
0.010
Why?
Interleukin-5
2
1998
42
0.010
Why?
Diagnosis, Differential
1
2009
1498
0.010
Why?
DNA Replication
1
2006
240
0.010
Why?
Mice, Transgenic
2
2000
2180
0.010
Why?
Age Distribution
1
2005
395
0.010
Why?
Sex Distribution
1
2005
379
0.010
Why?
Creatinine
2
1997
489
0.010
Why?
Vaccines
1
2009
406
0.010
Why?
Abdominal Neoplasms
1
2003
47
0.010
Why?
Lung
1
1996
4134
0.010
Why?
Endemic Diseases
1
2003
36
0.010
Why?
Disease Progression
1
2010
2793
0.010
Why?
Peptide Fragments
2
1998
698
0.010
Why?
Neuroblastoma
1
2003
163
0.010
Why?
Sequence Analysis, DNA
1
2005
824
0.010
Why?
Bioelectric Energy Sources
1
2001
4
0.010
Why?
Fibrosarcoma
1
2001
21
0.010
Why?
Electricity
1
2001
24
0.010
Why?
Galvanic Skin Response
1
2001
25
0.010
Why?
Electric Conductivity
1
2001
86
0.010
Why?
Actuarial Analysis
1
2001
22
0.010
Why?
Injections, Intravenous
1
2001
202
0.010
Why?
Anticoagulants
2
1996
675
0.010
Why?
Melanoma, Experimental
1
2001
111
0.010
Why?
Fingers
1
2001
106
0.010
Why?
HLA-A Antigens
1
2001
58
0.010
Why?
Myocardial Revascularization
1
2001
74
0.010
Why?
Statistics, Nonparametric
1
2001
434
0.010
Why?
Immune Sera
1
2000
84
0.010
Why?
Muscle, Smooth, Vascular
1
2003
450
0.010
Why?
Amino Acid Sequence
2
1994
2158
0.010
Why?
Probability
1
2001
309
0.010
Why?
Mice, Inbred C57BL
2
2001
5887
0.010
Why?
Clone Cells
1
2000
266
0.010
Why?
Databases as Topic
1
2000
69
0.010
Why?
Emergency Treatment
1
2001
125
0.010
Why?
Lymphocytes, Tumor-Infiltrating
1
2001
208
0.010
Why?
New York
1
2000
127
0.010
Why?
Carotid Artery Diseases
1
2000
62
0.010
Why?
Students
1
2005
645
0.010
Why?
Peripheral Vascular Diseases
1
2000
103
0.010
Why?
Columbidae
1
1998
31
0.010
Why?
Cytochrome c Group
1
1998
44
0.010
Why?
Cardiotonic Agents
1
1999
95
0.010
Why?
Lymph Nodes
1
2001
502
0.010
Why?
Cardiac Output
1
1999
177
0.010
Why?
Life Tables
1
1998
20
0.010
Why?
Temperature
1
2001
669
0.010
Why?
Endocardium
1
1998
31
0.010
Why?
Aortic Diseases
1
2000
119
0.010
Why?
Vascular Resistance
1
1999
364
0.010
Why?
Calcinosis
1
2000
238
0.010
Why?
Cell Death
1
1999
386
0.010
Why?
Hypotension
1
1998
122
0.010
Why?
Cardiopulmonary Bypass
1
2000
218
0.010
Why?
Renal Insufficiency
1
2000
169
0.010
Why?
Angiotensin-Converting Enzyme Inhibitors
1
1998
198
0.010
Why?
Phosphorylation
1
2002
1768
0.010
Why?
Ukraine
1
1997
22
0.010
Why?
Endocarditis, Bacterial
1
1997
46
0.010
Why?
Odds Ratio
1
2000
1052
0.010
Why?
Models, Structural
1
1996
41
0.010
Why?
Lung Volume Measurements
1
1996
47
0.010
Why?
Dose-Response Relationship, Drug
1
2001
2064
0.010
Why?
Radiometry
1
1997
54
0.010
Why?
Histocompatibility Antigens Class II
1
1998
369
0.010
Why?
Epidemiologic Methods
1
1997
96
0.010
Why?
Ultrasonography, Doppler, Transcranial
1
1996
44
0.010
Why?
Cardiac Output, Low
1
1996
46
0.010
Why?
Health Care Costs
1
2000
424
0.010
Why?
Equipment Failure
1
1996
111
0.010
Why?
Urogenital Neoplasms
1
1995
5
0.010
Why?
Europe
1
1997
410
0.010
Why?
Pneumonia, Viral
1
2001
374
0.010
Why?
Vital Capacity
1
1996
312
0.010
Why?
Neoplasms, Second Primary
1
1997
109
0.010
Why?
Heart Valve Prosthesis
1
1997
115
0.010
Why?
Models, Cardiovascular
1
1996
197
0.010
Why?
Blood Urea Nitrogen
1
1995
54
0.010
Why?
Forced Expiratory Volume
1
1996
489
0.010
Why?
Heart Rate
1
1999
821
0.010
Why?
Acute Disease
1
1998
1008
0.010
Why?
Aortic Aneurysm
1
1995
70
0.010
Why?
Child Development
1
2000
498
0.010
Why?
Hodgkin Disease
1
1997
157
0.010
Why?
Equipment Design
1
1996
525
0.010
Why?
Proportional Hazards Models
1
1998
1261
0.010
Why?
Biopsy
1
1998
1081
0.010
Why?
Waiting Lists
1
1996
244
0.010
Why?
Receptors, Antigen, T-Cell
1
1998
720
0.010
Why?
Heart Septal Defects, Ventricular
1
1994
45
0.010
Why?
Interviews as Topic
1
1997
844
0.010
Why?
Reoperation
1
1997
588
0.010
Why?
Pain, Postoperative
1
1997
309
0.010
Why?
Exercise Test
1
1996
625
0.010
Why?
Cell Adhesion
1
1994
468
0.010
Why?
Myocardium
1
1998
928
0.010
Why?
Thyroid Neoplasms
1
1997
327
0.010
Why?
Ventricular Function, Right
1
1995
283
0.010
Why?
Central Nervous System
1
1994
265
0.010
Why?
Patient Compliance
1
1997
610
0.010
Why?
Feasibility Studies
1
1996
1018
0.010
Why?
Smoking
1
2000
1601
0.010
Why?
Blood Pressure
1
1998
1748
0.010
Why?
Diabetes Mellitus
1
2000
1074
0.010
Why?
Head and Neck Neoplasms
1
1995
553
0.010
Why?
Lymphocyte Cooperation
1
1990
49
0.010
Why?
Receptors, Lymphocyte Homing
1
1990
16
0.010
Why?
Thymectomy
1
1990
15
0.010
Why?
Research Design
1
1997
1143
0.010
Why?
Antilymphocyte Serum
1
1990
59
0.010
Why?
Antigens, Surface
1
1990
156
0.000
Why?
Infectious Bovine Rhinotracheitis
1
1989
1
0.000
Why?
Phorbol Esters
1
1989
14
0.000
Why?
Ionomycin
1
1989
22
0.000
Why?
Rabbits
1
1990
754
0.000
Why?
Ethers
1
1989
19
0.000
Why?
Immunotherapy
1
1994
640
0.000
Why?
Isoantigens
1
1988
17
0.000
Why?
Kidney
1
1997
1482
0.000
Why?
Cell-Free System
1
1988
55
0.000
Why?
Surveys and Questionnaires
1
2000
5929
0.000
Why?
Breast Neoplasms
1
1997
2250
0.000
Why?
Models, Biological
1
1988
1828
0.000
Why?
Weinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)